Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
MIDAZOLAM INJECTION PFIZER CANADA ULC Actual shortage 1MG Updated Report 2019-09-21 82597
PRO-SOTALOL PRO DOC LIMITEE Actual shortage 80MG Updated Report 2019-09-21 91654
PRECEDEX PFIZER CANADA ULC Actual shortage 4MCG Updated Report 2019-09-21 93225
POTASSIUM CHLORIDE INJECTION BAXTER CORPORATION Actual shortage 14.9MG Updated Report 2019-09-21 94470
APO-GLIMEPIRIDE APOTEX INC Resolved 4MG Updated Report 2019-09-21 31007
APO-GLIMEPIRIDE APOTEX INC Resolved 1MG Updated Report 2019-09-21 32536
APO-GLIMEPIRIDE APOTEX INC Resolved 2MG Updated Report 2019-09-21 55281
FML 0.1% ALLERGAN INC Resolved 0.1% Updated Report 2019-09-21 91579
METHOTREXATE INJECTION USP PFIZER CANADA ULC Actual shortage 25MG Updated Report 2019-09-21 93692
LOCACORTEN VIOFORM EARDROPS PALADIN LABS INC Actual shortage 0.02% 1% Updated Report 2019-09-21 94432
5% DEXTROSE INJECTION, USP BAXTER CORPORATION Actual shortage 5G Updated Report 2019-09-21 94473
POTASSIUM CHLORIDE INJECTION BAXTER CORPORATION Actual shortage 7.46MG Updated Report 2019-09-20 89426
APO-RIVASTIGMINE APOTEX INC Actual shortage 1.5MG Updated Report 2019-09-20 20900
APO-RIVASTIGMINE APOTEX INC Actual shortage 4.5MG Updated Report 2019-09-20 85610
APO-RIVASTIGMINE APOTEX INC Actual shortage 3MG Updated Report 2019-09-20 86336
APO-RIVASTIGMINE APOTEX INC Actual shortage 6MG Updated Report 2019-09-20 88360
GENOTROPIN PFIZER CANADA ULC Actual shortage 1.4MG Updated Report 2019-09-20 93856
NOLVADEX-D TAB 20MG ASTRAZENECA CANADA INC Anticipated shortage 20MG Updated Report 2019-09-20 94235
RANITIDINE - 150 PRO DOC LIMITEE Actual shortage 150MG Updated Report 2019-09-20 94391
RANITIDINE - 300 PRO DOC LIMITEE Actual shortage 300MG Updated Report 2019-09-20 94394
0.9% SODIUM CHLORIDE INJECTION, USP BAXTER CORPORATION Actual shortage 900MG Updated Report 2019-09-20 94411
OLMETEC PLUS MERCK CANADA INC Actual shortage 12.5MG 20MG Updated Report 2019-09-19 90616
PREVYMIS MERCK CANADA INC Anticipated shortage 20MG Updated Report 2019-09-19 92759
SODIUM THIOSULFATE INJECTION USP HOPE PHARMACEUTICALS LTD Anticipated shortage 250MG Updated Report 2019-09-19 94406
PROQUAD MERCK CANADA INC Avoided shortage 4.30Log10 TCID50 3.99Log10 PFU 3.00Log10 TCID50 3.00Log10 TCID50 Updated Report 2019-09-19 90641
MYLAN-TADALAFIL MYLAN PHARMACEUTICALS ULC Actual shortage 20MG New Report 2019-09-19 94402
GONAL-F PEN EMD SERONO A DIVISION OF EMD INC CANADA Anticipated shortage 300UNIT Updated Report 2019-09-19 94397
DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML PFIZER CANADA ULC Actual shortage 150MG Updated Report 2019-09-19 88645
BREVICON 1/35 TABLETS (28-DAY PACK) PFIZER CANADA ULC Actual shortage 0.035MG 1MG Updated Report 2019-09-19 92052
ACT QUETIAPINE ACTAVIS PHARMA COMPANY Actual shortage 25MG New Report 2019-09-19 94384
TEVA-TAMOXIFEN TEVA CANADA LIMITED Actual shortage 20MG New Report 2019-09-19 94381
TEVA-CAPTOPRIL TEVA CANADA LIMITED Actual shortage 100MG New Report 2019-09-19 94378
TEVA-QUETIAPINE XR TEVA CANADA LIMITED Actual shortage 400MG New Report 2019-09-19 94375
TEVA-ATORVASTATIN TEVA CANADA LIMITED Actual shortage 80MG New Report 2019-09-19 94372
TEVA-IRBESARTAN TEVA CANADA LIMITED Actual shortage 150MG New Report 2019-09-19 94369
TEVA-ROSUVASTATIN TEVA CANADA LIMITED Resolved 40MG Updated Report 2019-09-19 92157
TEVA-RIZATRIPTAN ODT TEVA CANADA LIMITED Resolved 5MG Updated Report 2019-09-19 92151
NOVO-GESIC TEVA CANADA LIMITED Actual shortage 325MG Updated Report 2019-09-19 87680
AMPICILLIN SODIUM FOR INJECTION, USP TEVA CANADA LIMITED Resolved 250MG Updated Report 2019-09-19 93110
AMPICILLIN SODIUM FOR INJECTION, USP TEVA CANADA LIMITED Resolved 2000MG Updated Report 2019-09-19 86942
AMPICILLIN SODIUM FOR INJECTION, USP TEVA CANADA LIMITED Resolved 1000MG Updated Report 2019-09-19 86939
ACT RIZATRIPTAN ACTAVIS PHARMA COMPANY Actual shortage 10MG Updated Report 2019-09-19 93169
ACT BUPROPION XL ACTAVIS PHARMA COMPANY Actual shortage 300MG Updated Report 2019-09-19 68580
ACT BUPROPION XL ACTAVIS PHARMA COMPANY Actual shortage 300MG Updated Report 2019-09-19 68577
ACT BUPROPION XL ACTAVIS PHARMA COMPANY Actual shortage 150MG Updated Report 2019-09-19 68569
TEVA-QUETIAPINE XR TEVA CANADA LIMITED Actual shortage 300MG Updated Report 2019-09-19 93656
TEVA-SOLIFENACIN TEVA CANADA LIMITED Actual shortage 5MG Updated Report 2019-09-19 93149
TEVA-MODAFINIL TEVA CANADA LIMITED Actual shortage 100MG Updated Report 2019-09-19 93137
TEVA-SUCRALFATE TEVA CANADA LIMITED Actual shortage 1G Updated Report 2019-09-19 92663
VINBLASTINE SULPHATE INJECTION TEVA CANADA LIMITED Actual shortage 1MG Updated Report 2019-09-19 92198

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-SOLIFENACIN APOTEX INC Discontinued 10MG Updated Report 2019-09-20 78269
APO-SOLIFENACIN APOTEX INC Discontinued 5MG Updated Report 2019-09-20 78272
APO-GLIMEPIRIDE APOTEX INC Discontinued New Report 2019-09-20 94452
APO-GLIMEPIRIDE APOTEX INC Discontinued New Report 2019-09-20 94449
APO-GLIMEPIRIDE APOTEX INC Discontinued New Report 2019-09-20 94446